Illumina Inc (ILMN)
154.98
+1.40
(+0.91%)
USD |
NASDAQ |
Nov 05, 16:00
154.99
+0.02
(+0.01%)
After-Hours: 18:55
Illumina Revenue (Quarterly): 1.112B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.112B |
| March 31, 2024 | 1.076B |
| December 31, 2023 | 1.122B |
| September 30, 2023 | 1.119B |
| June 30, 2023 | 1.176B |
| March 31, 2023 | 1.087B |
| December 31, 2022 | 1.083B |
| September 30, 2022 | 1.115B |
| June 30, 2022 | 1.162B |
| March 31, 2022 | 1.223B |
| December 31, 2021 | 1.199B |
| September 30, 2021 | 1.108B |
| June 30, 2021 | 1.126B |
| March 31, 2021 | 1.093B |
| December 31, 2020 | 953.00M |
| September 30, 2020 | 794.00M |
| June 30, 2020 | 633.00M |
| March 31, 2020 | 859.00M |
| December 31, 2019 | 952.00M |
| September 30, 2019 | 907.00M |
| June 30, 2019 | 838.00M |
| March 31, 2019 | 846.00M |
| December 31, 2018 | 867.00M |
| September 30, 2018 | 853.00M |
| June 30, 2018 | 830.00M |
| Date | Value |
|---|---|
| March 31, 2018 | 782.00M |
| December 31, 2017 | 777.00M |
| September 30, 2017 | 714.00M |
| June 30, 2017 | 662.00M |
| March 31, 2017 | 598.00M |
| December 31, 2016 | 619.00M |
| September 30, 2016 | 607.00M |
| June 30, 2016 | 600.00M |
| March 31, 2016 | 572.00M |
| December 31, 2015 | 591.79M |
| September 30, 2015 | 550.27M |
| June 30, 2015 | 539.38M |
| March 31, 2015 | 538.56M |
| December 31, 2014 | 512.38M |
| September 30, 2014 | 480.63M |
| June 30, 2014 | 447.57M |
| March 31, 2014 | 420.78M |
| December 31, 2013 | 387.33M |
| September 30, 2013 | 356.80M |
| June 30, 2013 | 346.09M |
| March 31, 2013 | 330.96M |
| December 31, 2012 | 309.26M |
| September 30, 2012 | 285.87M |
| June 30, 2012 | 280.61M |
| March 31, 2012 | 272.77M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
633.00M
Minimum
Jun 2020
1.223B
Maximum
Mar 2022
1.052B
Average
1.108B
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Exact Sciences Corp | 699.26M |
| Delcath Systems Inc | 7.766M |
| Star Equity Holdings Inc | 13.48M |
| CytoSorbents Corp | 8.842M |
| Progyny Inc | 304.09M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.988B |
| Total Expenses (Quarterly) | 863.00M |
| EPS Diluted (Quarterly) | -12.48 |
| Enterprise Value | 25.70B |
| Gross Profit Margin (Quarterly) | 64.84% |
| Profit Margin (Quarterly) | -178.8% |
| Earnings Yield | -12.36% |
| Operating Earnings Yield | 0.21% |
| Normalized Earnings Yield | -2.946 |